Literature DB >> 16381007

Contact of high-invasive, but not low-invasive, melanoma cells to native collagen I induces the release of mature cathepsin B.

Anke Klose1, Astrid Wilbrand-Hennes, Paola Zigrino, Ekkehard Weber, Thomas Krieg, Cornelia Mauch, Nicolas Hunzelmann.   

Abstract

Metastasis of malignant tumor cells involves cell-cell and cell-matrix interactions, which regulate the expression and localization of proteolytic enzymes. In the present study, we investigated the expression and localization of the lysosomal cysteine proteinase cathepsin B and its natural inhibitors cystatin A, B and C in high- (MV3), intermediate- (SKmel28) and low-invasive (SKmel23, WM164) human melanoma cell lines grown on plastic or in contact with monomeric or fibrillar collagen type I. Neither the transcript levels of cathepsin B nor those of the natural inhibitors, cystatin B and C, were altered by the interaction of melanoma cells with collagen type I. However, protein expression and cellular localization of cathepsin B and its inhibitors were markedly affected. In contrast to low-invasive cells, high-invasive cells constitutively released procathepsin B when cultured on plastic. In addition, contact of invasive cells with fibrillar collagen type I resulted in the release of both mature forms of the protease. Perturbation studies using inhibitory antibodies against the beta1 subunit of the integrin receptor indicated a role for the beta1 integrin receptor family in the regulation of cathepsin B release. Cystatin B protein expression was much lower in high-invasive cells in both culture conditions, when compared to low-invasive cells. Cystatin C expression was comparable in all cells, but cell contact to fibrillar collagen type I induced its expression. These results strongly implicate a pivotal role of cell-matrix interactions for the regulation of cathepsin B localization and activity in melanoma cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16381007     DOI: 10.1002/ijc.21700

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Comparative proteomic analysis of a cytosolic fraction from β3 integrin-deficient cells.

Authors:  Jason A Bush; Hideki Kitaura; Yuliang Ma; Steven L Teitelbaum; F Patrick Ross; Jeffrey W Smith
Journal:  Cancer Genomics Proteomics       Date:  2012-01       Impact factor: 4.069

Review 2.  Cathepsin B: multiple roles in cancer.

Authors:  Neha Aggarwal; Bonnie F Sloane
Journal:  Proteomics Clin Appl       Date:  2014-03-26       Impact factor: 3.494

3.  Cathepsin B is the driving force of esophageal cell invasion in a fibroblast-dependent manner.

Authors:  Claudia D Andl; Kelsey M McCowan; Gillian L Allison; Anil K Rustgi
Journal:  Neoplasia       Date:  2010-06       Impact factor: 5.715

4.  Imaging bone morphogenetic protein 7 induced cell cycle arrest in experimental gliomas.

Authors:  Anke Klose; Yannic Waerzeggers; Parisa Monfared; Slobodan Vukicevic; Eric L Kaijzel; Alexandra Winkeler; Claudia Wickenhauser; Clemens W G M Löwik; Andreas H Jacobs
Journal:  Neoplasia       Date:  2011-03       Impact factor: 5.715

5.  Post-translational regulation of cathepsin B, but not of other cysteine cathepsins, contributes to increased glioblastoma cell invasiveness in vitro.

Authors:  Boris Gole; María Beatriz Durán Alonso; Vincenc Dolenc; Tamara Lah
Journal:  Pathol Oncol Res       Date:  2009-05-13       Impact factor: 3.201

6.  Functional live-cell imaging demonstrates that beta1-integrin promotes type IV collagen degradation by breast and prostate cancer cells.

Authors:  Mansoureh Sameni; Julie Dosescu; Kenneth M Yamada; Bonnie F Sloane; Dora Cavallo-Medved
Journal:  Mol Imaging       Date:  2008 Sep-Oct       Impact factor: 4.488

7.  Cathepsins B and D drive hepatic stellate cell proliferation and promote their fibrogenic potential.

Authors:  Anna Moles; Núria Tarrats; José C Fernández-Checa; Montserrat Marí
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

8.  Expression and function of the kallikrein-related peptidase 6 in the human melanoma microenvironment.

Authors:  Stefanie Krenzer; Heike Peterziel; Cornelia Mauch; Sachiko I Blaber; Michael Blaber; Peter Angel; Jochen Hess
Journal:  J Invest Dermatol       Date:  2011-07-14       Impact factor: 8.551

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.